🔎 Trials Near Me

Akèy › Leksemi biphenotipik egi › New Jersey › Edison

Etid klinik pou Leksemi biphenotipik egi nan Edison, NJ

4 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi lwen
365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • Saint Peter's University Hospital, New Brunswick · 3 mi lwen
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi lwen
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Ap rekriteFaz 1/2
  • Saint Peter's University Hospital, New Brunswick · 3 mi lwen
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi lwen
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241

A Study of Revumenib and Mezigdomide in People With Leukemia

Ap rekriteFaz 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Laj 12 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT07356154

Etid Leksemi biphenotipik egi nan lòt vil

Lòt etid nan Edison

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.